Novartis donates Rs 16 Crore gene therapy to 23 month old Spinal Muscular Atrophy Type 1 patient
A 23-month-old baby with Spinal Muscular Atrophy (SMA) Type 1, received a new lease of life with Swiss drugmaker Novartis coming forward to donate gene therapy costing Rs 16 crore.Baby Ellen was administered Zolgensma gene therapy, called the world's costliest drug, at a private hospital in Hyderabad on August 6, her father Rayapudi Praveen said on Sunday.For more details, check out the...
A 23-month-old baby with Spinal Muscular Atrophy (SMA) Type 1, received a new lease of life with Swiss drugmaker Novartis coming forward to donate gene therapy costing Rs 16 crore.
Baby Ellen was administered Zolgensma gene therapy, called the world's costliest drug, at a private hospital in Hyderabad on August 6, her father Rayapudi Praveen said on Sunday.
For more details, check out the full story on the link mentioned below:
Novartis Donates Rs 16 Crore Drug To 23 Month Old Spinal Muscular Atrophy Type 1 Patient
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd